纪建松

导师简介

纪建松，男，博士研究生，主任医师、教授，博士生导师、硕士生导师。

职务

浙江省影像诊断与介入微创研究重点实验室主任

浙江大学丽水医院、丽水市中心医院党委副书记、副院长

学习经历

1994/09-1999/06 温州医科大学，临床医学

2001/09-2003/06 苏州大学，影像医学与核医学

2005/09-2008/06 浙江大学，临床医学

2010/01-2013/01 东南大学附属中大医院，介入放射学

2015/06-2016/05 美国华盛顿大学，介入放射学

工作经历

1993/08-2003/09 丽水市中心医院，住院医师

2003/09-2004/12 丽水市中心医院，放射科主任助理

2004/12-2009/06 丽水市中心医院，放射科副主任

2009/06-2011/10 丽水市中心医院，放射科主任

2011/10-2013/10 丽水市中心医院，院长助理，放射科主任

2013/10-2016/05 丽水市中心医院，党委委员，院长助理，放射科主任

2016/05-2016/09 丽水市中心医院，党委委员，副院长，放射科主任

2016/09-2020/07 丽水市中心医院，党委委员，副院长，放射科主任兼介入诊疗中心主任

2020/07-至今 丽水市中心医院，党委副书记，副院长

教学科研信息简介

目前本人任浙江大学博士生导师、温州医科大学博士生导师、中科院苏州医工所博士生导师；先后培养博士后、博士及硕士研究生30余名。主持国家自然基金和省部级科研项目10余项（其中国家重点研发计划1项，国家自然科学基金面上项目2项，省重大科技专项1项，省重点研发计划项目1项）， 市厅级科研13项。发明专利4项，实用新型21项。发表论文200余篇，SCI研究论文93篇，TOP期刊23篇，主编专著5部，参编/译4部。研究成果荣获省部级奖励7项，厅级奖励18项。

学术兼职

中国医师协会介入医师分会急诊介入专委会副主任委员

中国抗癌协会肿瘤介入学专业委员会青年委员会副主任委员

中国抗癌协会肿瘤微创治疗专业委员会常委

中国抗癌协会肿瘤微创治疗专业委员会肿瘤急症微创治疗分会常委

浙江省数理医学学会人工智能影像与介入医学专业委员会主任委员

《中华医学杂志》通讯编委《中华放射学杂志》、《介入放射学杂志》等杂志编委，《European Radiology》、《Journal of Hepatology》等杂志审稿专家。国家重点研发计划政府间/港澳台重点专项项目评审专家、国家自然基金评审专家。

主要研究方向：放射影像学

主要研究内容：胸腹部影像诊断、血管性疾病及肿瘤介入综合治疗方向

目前承担的主要研究任务：

1．2020-2022年，国家重点研发国际合作项目《基于肿瘤微环境稳态的均一尺寸多功能栓塞微球的研发及其介入协同疗效研究》，立项号：2018YFE0126900， 1/23，科研经费296万元

2．2021-2024年，国家自然科学基金面上项目《基于靶向递药纳米结构的溶蚀性可视化栓塞微球的级联肝癌介入治疗研究》，立项号：82072026， 1/8，科研经费55万元

3．2018-2020年，浙江省重点研发计划《高发恶性肿瘤诊治新技术研究-肝癌局部消融计划系统开发及关键技术研究》，立项号：2018C03024， 1/10，科研经费135万元

4．2019-2021年，丽水市重点研发计划《多模态影像融合的肝癌精准实时适形消融计划导航关键技术开发》，立项号：2019ZDYF17， 1/8，科研经费80万元

近三年发表的主要论文：

1.Xiaojuan Wang, Chenhan Peng, Shuo Zhang, Xiaoling Xu, Gaofeng Shu, Jing Qi, Yafang Zhu, Demin Xu, Xuqi Kang, Kongjun Lu, Feiyang Jin, Risheng Yu, Xiaoying Ying, Jian You, Yongzhong Du*, Jiansong Ji*. Polysialic-Acid-Based Micelles Promote Neural Regeneration in Spinal Cord Injury Therapy. Nano Letters, 2019, 19(2): 829-838(SCI)

2.Zhongwei Zhao#, Liyun Zheng#, Weiqian Chen, Wei Weng, Jingjing Song, Jiansong Ji*. Delivery strategies of cancer immunotherapy: recent advances and future perspectives. Journal of Hematology & Oncology, 2019, 12(1): 126(SCI)

3.Di Liu, Feiyang Jin, Gaofeng Shu, Xiaoling Xu, Jing Qi, Xuqi Kang, Hui Yu, Kongjun Lu, Saiping Jiang∗, Feng Han, Jian You, Yongzhong Du∗, Jiansong Ji∗. Enhanced efciency of mitochondria-targeted peptide SS-31 for acute kidney injury by pH-responsive and AKI-kidney targeted nanopolyplexes. Biomaterials, 2019, 211: 57–67(SCI)

4.Xiaojuan Wang, Gaofeng Shu, Xiaoling Xu, Chenhan Peng, Chenying Lu, Xingyao Cheng, Xiangchao Luo, Jie Li, Jing Qi, Xuqi Kang, Feiyang Jin, Minjiang Chen, Xiaoying Ying, Jian You, Yongzhong Du*, Jiansong Ji*. Combinational protective therapy for spinal cord injury medicated by sialic acid-driven and polyethylene glycol based micelles. Biomaterials, 2019, 217: 119326(SCI)

5.Jing Qi#, Weishuo Li#, Xiaoling Xu, Feiyang Jin, Di Liu, Yan Du, Jun Wang, Xiaoying Ying, Jian You, Yongzhong Du*, Jiansong Ji*. Cyto-friendly polymerization at cell surface modulates cell fate by clustering cell-surface receptor. Chemical Science, 2020, 11(16): 4221-4225

6.Gaofeng Shu#, Minjiang Chen#, Jingjing Song#, Xiaoling Xu, Chenying Lu, Yuyin Du, Min Xu, Zhongwei Zhao, Minxia Zhu, Kai Fan, Xiaoxi Fan, Shiji Fang, Bufu Tang, Yiyang Dai, Yongzhong Du*, Jiansong Ji*. Sialic acid-engineered mesoporous polydopamine nanoparticles loaded with SPIO and Fe3+ as a novel theranostic agent for T1/T2 dual-mode MRI-guided combined chemo-photothermal treatment of hepatic cancer. Bioactive Materials, 2021, 6(5): 1423-1435

7.Jiansong Ji#, Qiaoyou Weng#, Feng Zhang, Fu Xiong, Yin Jin, Junguo Hui, Jingjing Song, Jun Gao, Minjiang Chen, Qiang Li, David Shin, Xiaoming Yang*. Non-Small-Cell Lung Cancer: Feasibility of Intratumoral Radiofrequency Hyperthermia-enhanced Herpes Simplex Virus Thymidine Kinase Gene Therapy. Radiology, 2018, 288(2): 612-620

8.Minjiang Chen#, Aiwu Mao#, Min Xu, Qiaoyou Weng, Jianting Mao, Jiansong Ji∗. CRISPR-Cas9 for cancer therapy: Opportunities and challenges. Cancer Letters, 2019, 447: 48-55

9.Xiaoxi Fan#, Jingjing Song#, Zhongwei Zhao#, Minjiang Chen, Jianfei Tu, Chenying Lu, Fazong Wu, Dengke Zhang, Qiaoyou Weng, Liyun Zheng, Min Xu∗, Jiansong Ji∗. Piplartine suppresses proliferation and invasion of hepatocellular carcinoma by LINC01391-modulated Wnt/β-catenin pathway inactivation through ICAT. Cancer Letters, 2019, 460: 119-127

10.Weiqi Xu#, Ken Liu#, Minjiang Chen, Jinyu Sun, Geoffrey W McCaughan, Xiaojie Lu*, Jiansong Ji*. Immunotherapy for hepatocellular carcinoma: recent advances and future perspectives. Therapeutic Advances in Medical Oncology, 2019, 11: 1758835919862692

11.Jiansong Ji#, Weiqian Chen#, Weishuai Lian, Ruijie Chen, Jinqing Yang, Qianqian Zhang, Qiaoyou Weng,Zia Khan, Jie Hu, Xi Chen, Peng Zou, Xiaoming Chen*, Guang Liang*. (S)-crizotinib reduces gastric cancer growth through oxidative DNA damage and triggers pro-survival akt signal. Cell Death & Disease, 2018, 9(6): 660

12.Min Xu#, Shiji Fang#, Jingjing Song#, Minjiang Chen, Qianqian Zhang, Qiaoyou Weng, Xiaoxi Fan, Weiqian Chen, Xulu Wu, Fazong Wu, Jianfei Tu, Zhongwei Zhao*, Jiansong Ji*. CPEB1 mediates hepatocellular carcinoma cancer stemness and chemoresistance. Cell Death & Disease, 2018, 9(10): 957-974

13.Nannan Zhang#, Chenying Lu#, Gaofeng Shu, Jie Li, Minjiang Chen, Chunmiao Chen, Xiuling Lv, Xiaoling Xu, Wei Weng, Qiaoyou Weng, Bufu Tang, YongZhong Du*, Jiansong Ji*. Gadolinium-loaded calcium phosphate nanoparticles for magnetic resonance imaging of orthotopic hepatocarcinoma and primary hepatocellular carcinoma. Biomaterials Science, 2020, 8(7): 1961-1972

14.Minjiang Chen#, Liming Wu#, Jianfei Tu#, Zhongwei Zhao, Xiaoxi Fan, Jianting Mao, Qiaoyou Weng, Xulu Wu, Li Huang*, Min Xu*, Jiansong Ji*. miR-590-5p suppresses hepatocellular carcinoma chemoresistance by targeting YAP1 expression. EBioMedicine, 2018, 35: 142-154

15.Jianfei Tu#,Zhongwei Zhao#, Min Xu#, Xiaojie Lu, Liu Chang*, Jiansong Ji*. NEAT1 upregulates TGF-β1 to induce hepatocellular carcinoma progression by sponging hsa-mir-139-5p. Journal of Cellular Physiology, 2018, 233(11): 8578-8587

16.Jianfei Tu#, Zhongwei Zhao#, Min Xu#, Minjiang Chen, Qiaoyou Weng, Jiangmei Wang*, Jiansong Ji*. LINC00707 contributes to hepatocellular carcinoma progression via sponging miR‐206 to increase CDK14. Journal of Cellular Physiology, 2019, 234(7): 10615-10624

17.Bufu Tang#, Jinyu Zhu#, Ying Cong#, Weibin Yang, Chunli Kong, Weiyue Chen, Yajie Wang, Yong Zeng, Jiansong Ji*. The Landscape of Coronavirus Disease 2019 (COVID-19) and Integrated Analysis SARS-CoV-2 Receptors and Potential Inhibitors in Lung Adenocarcinoma Patients. Frontiers in Cell and Developmental Biology, 2020

18.Nannan Zhang#, Risheng Yu#, Min Xu#, Xingyao Cheng, Chunmiao Chen, Xiaoling Xu, Chenying Lu, Kongjun Lu, Minjiang Chen, Menglu Zhu, Qiaoyou Weng, Junguo Hui, Qian Zhang, Yongzhong Du*, Jiansong Ji*. Visual targeted therapy of hepatic cancer using homing peptide modified calcium phosphate nanoparticles loading doxorubicin guided by T1 weighted MRI. Nanomedicine: Nanotechnology, Biology and Medicine, 2018, 14(7): 2167-2178

19.Qiaoyou Weng#, Minjiang Chen#, Weibin Yang#, Jie Li, Kai Fan, Min Xu, Wei Weng, Xiuling Lv, Shiji Fang, Liyun Zheng, Jingjing Song, Zhongwei Zhao, Xiaoxi Fan*, Jiansong Ji*. Integrated analyses identify miR-34c-3p/MAGI3 axis for the Warburg metabolism in hepatocellular carcinoma. FASEB Journal, 2020, 34(4): 5420-5434

20.Qiaoyou Weng#, Minjiang Chen#, Maoquan Li, Yongfa Zheng, Guoliang Shao, Weijun Fan, Ximing Xu*, Jiansong Ji*. Global microarray profiling identified hsa_circ_0064428 as a potential immune-associated prognosis biomarker for hepatocellular carcinoma. Journal of Medical Genetics, 2019, 56(1): 32-38

21.Jiansheng Huang#, Xiaolei Hu#, Yunan Zhao, Yang Shi, Hui Ding, Rongzhen Wu, Zhigang Zhao*, Jiansong Ji*. Comparative analysis of bla KPC expression in Tn4401 transposons and the Tn3-Tn4401 chimaera. Antimicrobial Agents and Chemotherapy, 2019, 63(5): e02434-18

22.Jinyu Sun1#, Dengke Zhang#, Songquan Wu, Min Xu, Xiao Zhou, XiaoJie Lu*, Jiansong Ji*. Resistance to PD-1/PD-L1 blockade cancer immunotherapy: mechanisms, predictive factors, and future perspectives. Biomarker Research, 2020, 8: 35

23.Zhongwei Zhao#, Lili Yang#, Shiji Fang#, Liyun Zheng, Fazong Wu, Weiqian Chen, Jingjing Song, Minjiang Chen, Jiansong Ji*. The Effect of m6A Methylation Regulatory Factors on the Malignant Progression and Clinical Prognosis of Hepatocellular Carcinoma. Frontiers in Oncology , 2020, 10: 1435

24.Jinyu Zhu#, Bufu Tang#, Jie Li, Yueli Shi, Minjiang Chen, Xiuling Lv, Miaomiao Meng, Qiaoyou Weng, Nannan Zhang, Kai Fan, Min Xu*, Jiansong Ji*. Identification and Validation of the Angiogenic Genes for Constructing Diagnostic, Prognostic, and Recurrence Models for Hepatocellular Carcinoma. Aging-US, 2020, 12(9): 7848-7873

25.Jianfei Tu#, Zhongwei Zhao#, Min Xu#, Minjiang Chen, Qiaoyou Weng, Jiansong Ji*. LINC00460 promotes hepatocellular carcinoma development through sponging miR-485-5p to up-regulate PAK1. Biomedicine & Pharmacotherapy, 2019, 118: 109213

26.Chenying Lu#, Shiji Fang#, Qiaoyou Weng#, Xiuling Lv, Miaomiao Meng, Jinyu Zhu, Liyun Zheng, Yumin Hu, Yang Gao, Xulu Wu, Jianting Mao, Bufu Tang, Zhongwei Zhao, Li Huang*, Jiansong Ji*. Integrated analysis reveals critical glycolytic regulators in hepatocellular carcinoma. Cell Communication and Signaling, 2020, 18(1): 97

27.Bufu Tang#, Jinyu Zhu#, Jie Li, Kai Fan, Yang Gao, Shimiao Cheng, Chunli Kong, Liyun Zheng, Fazong Wu, Qiaoyou Weng, Chenying Lu*, Jiansong Ji*. The ferroptosis and iron-metabolism signature robustly predicts clinical diagnosis, prognosis and immune microenvironment for hepatocellular carcinoma. Cell Communication and Signaling, 2020, 18(1): 174

28.Feiyang Jin, Di Liu, Hui Yu, Jing Qi, Yuchan You, Xiaoling Xu, Xuqi Kang, Xiaojuan Wang, Kongjun Lu, Xiaoying Ying, Jian You, Yongzhong Du*, Jiansong Ji*. Sialic Acid-Functionalized PEG-PLGA Microspheres Loading Mitochondrial-Targeting-Modified Curcumin for Acute Lung Injury Therapy. Molecular Pharmaceutics, 2019, 16(1): 71-85

29.Jinmao Li#, Jun Zhou#, Zhen Xu*, Haijin Huang, Minjiang Chen, Jiansong Ji*. MicroRNA-27a-3p inhibits cell viability and migration through down-regulating DUSP16 in hepatocellular carcinoma. Journal of Cellular Biochemistry, 2018, 119(7): 5143-5152

30.Qianqian Zhang, Weiqian Chen, Xiuling Lv, Qiaoyou Weng, Minjiang Chen, Ri Cui, Guang Liang* , Jiansong Ji*. Piperlongumine, a Novel TrxR1 Inhibitor, Induces Apoptosis in Hepatocellular Carcinoma Cells by ROS-Mediated ER Stress. Frontiers in Pharmacology, 2019, 10: 1180

31.Weiqian Chen#, Minjiang Chen #, Zhongwei Zhao#, Qiaoyou Weng, Jingjing Song, Shiji Fang, Xulu Wu, Hailin Wang, Dengke Zhang, Weibin Yang, Zufei Wang, Min Xu*, Jiansong Ji*. ZFP36 Binds With PRC1 to Inhibit Tumor Growth and Increase 5-Fu Chemosensitivity of Hepatocellular Carcinoma. Frontiers in Molecular Biosciences, 2020, 14(7): 126

32.Shiji Fang#, Dengke Zhang#, Wei Weng, Xiuling Lv, Liyun Zheng, Minjiang Chen, Xiaoxi Fan, Jianting Mao, Chenchen Mao, Yani Ye, Min Xu*, Jiansong Ji*. CPSF7 regulates liver cancer growth and metastasis by facilitating WWP2-FL and targeting the WWP2/PTEN/AKT signaling pathway. biochimica et biophysica acta-molecular cell research, 2020, 1867(2): 118624

33.Zhongwei Zhao, Jingjing Song, Dengke Zhang, Fazong Wu, Jianfei Tu, Jiansong Ji*. Oxysophocarpine suppresses FGFR1-overexpressed hepatocellular carcinoma growth and sensitizes the therapeutic effect of lenvatinib. Life Sciences, 2020,118642(SCI)

34.Haidong Zhu#, Jinhe Guo#, Ming Huang#, Jiansong Ji#, Hao Xu#, Jian Lu#, Hailiang Li, WenHui Wang, Yuliang Li, Caifang Ni, Haibin Shi, Enhua Xiao, Weifu Lv, Junhui Sun, Ke Xu, Guohong Han, Linan Du, Weixin Ren, Maoquan Li, Aiwu Mao, Hua Xiang, Kaixian Zhang, Jie Min, Guangyu Zhu, Chang Su, Li Chen, Gaojun Teng*. Irradiation stents vs. conventional metal stents for unresectable malignant biliary obstruction: A multicenter trial. Journal of Hepatology , 2018, 68(5): 970–977(SCI)

35.Jing Qi, Weishuo Li, Kongjun Lu, Feiyang Jin, Di Liu, Xiaoling Xu, Xiaojuan Wang, Xuqi Kang, Wei Wang, Gaofeng Shu, Feng Han, Xiaoying Ying, Jian You*, Jiansong Ji*, Yongzhong Du*. pH and Thermal Dual-Sensitive Nanoparticle-Mediated Synergistic Antitumor Effect of Immunotherapy and Microwave Thermotherapy. Nano Letters, 2019, 19(8): 4949-4959(SCI)

36.Liping Huang*, Longfei Ding, Jun Zhou, Shuiliang Chen, Fang Chen, Chen Zhao, Jianqing Xu*, Wenjun Hu*, Jiansong Ji*, Hao Xu*, Gang L. Liu*. One-step rapid quantification of SARS-CoV-2 virus particles via low-cost nanoplasmonic sensors in generic microplate reader and point-of-care device. Biosensors & Bioelectronics, 2020, 171(): 112685(SCI)

37.Xiaoling Xu, Kongjun Lu, Menglu Zhu, Yanglong Du, Yafang Zhu,Nannan Zhang, Xiaojuan Wang, Xuqi Kang, Demin Xu, Xiaoying Ying,Risheng Yu, Chenying Lu, Jiansong Ji*, Jian You, Yongzhong Du*. Sialic Acid-functionalized pH-triggered Micelles for Enhanced Tumor Tissue Accumulation and Active Cellular Internalization of Orthotopic Hepatocarcinoma. ACS Applied Materials & Interfaces, 2018, 10(38): 31903–31914(SCI)

38.Feiyang Jin, Jing Qi, Minxia Zhu, Di Liu, Yuchan You, Gaofeng Shu, Yan Du, Jun Wang, Hui Yu, Mingchen Sun, Xiaoling Xu, Qiying Shen, Xiaoying Ying, Jiansong Ji*, Yongzhong Du*. NIR-Triggered Sequentially Responsive Nanocarriers Amplified Cascade Synergistic Effect of Chemo-Photodynamic Therapy with Inspired Antitumor Immunity . ACS Applied Materials & Interfaces, 2020, 12(29): 32372-32387(SCI)

39.Xiaoling Xu, Gaofeng Shu, Xiaojuan Wang, Jing Qi, Feiyang Jin, Qiying Shen, Xiaoying Ying*, Jiansong Ji*, Yongzhong Du*. Sialic acid-modifed chitosan oligosaccharide-based biphasic calcium phosphate promote synergetic bone formation in rheumatoid arthritis therapy. Journal of Controlled Release, 2020, 323: 578-590(SCI)

40.Yunbin Zhang#, Jingjing Song#, Zhongwei Zhao#, Mengxuan Yang, Ming Chen, Chenglong Liu, Jiansong Ji*, Di Zhu*. Single-cell transcriptome analysis reveals tumor immune microenvironment heterogenicity and granulocytes enrichment in colorectal cancer liver metastases. Cancer Letters, 2020, 470: 84-94(SCI)

41.Zhen Xiang#, Yiyao Qi#, Yusheng Lu#, Zhenrong Hu, Xiao Wang, Wenwen Jia*, Jingzhou Hu*, Jiansong Ji*, Wei Lu*. MOF-derived novel porous Fe3O4@C nanocomposites as smart nanomedical platforms for combined cancer therapy: magnetic-triggered synergistic hyperthermia and chemotherapy. Journal of Materials Chemistry B, 2020, 8(37): 8671-8683(SCI)

42.Zhiyong Zhou, Jianfei Tu, Chen Geng, Jisu Hu, Baotong Tong, Jiansong Ji*, Yakang Dai*. Accurate and Robust Non-rigid Point Set Registration using Student’s-t Mixture Model with Prior Probability Modeling. Scientific Reports,2018,8(1):8742(SCI)

43.Jingjing Song#, Feng Zhang#, Jiansong Ji#, Minjiang Chen, Qiang Li, Qiaoyou Weng, Shannon Gu, Matthew J. Kogut, Xiaoming Yang*. Orthotopic hepatocellular carcinoma: molecular imaging-monitored intratumoral hyperthermia-enhanced direct oncolytic virotherapy. International Journal of Hyperthermia, 2019, 36(1): 344-350(SCI)

44.Qing Zhou, Zhiyong Zhou, Chunmiao Chen, Guohua Fan, Guangqiang Chen, Haiyan Heng, Jiansong Ji*, Yakang Dai*. Grading of hepatocellular carcinoma using 3D SE-DenseNet in dynamic enhanced MR images. Computers in Biology and Medicine, 2019, 107: 47-57(SCI)

45.方世记, 郑丽云, 程适妙, 吴徐璐, 翁巧优, 陈敏江, 纪建松*. TACE 联合 RFA 治疗中晚期肝癌后早期复发相关危险因素研究. 中华介入放射学电子杂志, 2019, 7(2):106-110

46.应希慧, 涂建飞, 陈丽, 张登科, 吴发宗, 纪建松*. TACE 联合 RFA 及 125I 放射性粒子植入治疗巨块型肝癌的临床效果. 中华介入放射学电子杂志, 2019, 7(2): 101-105

47.方世记, 高瑞杰, 郑丽云, 赵中伟, 范晓希, 宋晶晶, 张登科, 吴发宗, 纪建松*. 125I放射性粒子植入在肝动脉化疗栓塞序贯射频消融治疗包膜下肝癌的临床价值 . 中华医学杂志, 2018, 98(47): 3853-3857

48.陈丽, 应希慧, 涂建飞, 张登科, 吴发宗, 纪建松*. 射频消融联合其他介入综合技术治疗原发性肝癌研究进展. 中华介入放射学电子杂志, 2019, 7(1): 75-80

49.李炳荣, 肖扬锐, 罗项超, 雷丽燕, 赵雪妙, 钟屹, 周利民, 纪建松*. 肝内胆管细胞癌与不典型肝脓肿的MRI鉴别诊断. 中华放射学杂志, 2019, 53(5): 370-374

50.程雪, 余日胜, 徐民, 吴徐璐, 陈春妙, 刘伟文, 纪建松*. 乳腺癌的功能磁共振成像征象与人表皮生长因子受体2表达差异的相关性分析. 中华医学杂志, 2019, 99(31): 2440-2444

51.徐民，程雪，赵中伟，宋晶晶，杨伟斌，吴徐璐，陈敏江，程星遥，范晓希，刘丽霞，纪建松*. 超声、CT、MRI及DSA在肝癌介入综合治疗术后肿瘤活性评估中的对比价值研究. 介入放射学杂志,2018,27(4):363-366

52.陈丽, 余日胜, 赖林强, 应希慧, 吴发宗, 张登科, 胡晓蕾, 王祖飞, 涂建飞, 纪建松*. 髓源性抑制细胞监测在评估中晚期肝癌TACE预后中的临床价值. 介入放射学杂志, 2019, 28(8): 742-746

近三年公开出版的专著或教材

1.《新冠肺炎CT早期征象与鉴别诊断》 科学出版社，主编，2020年4月出版，ISBN 978-7-03-064456-5

2.《实用CT诊断手册》 科学出版社，主编，2019年11月出版，ISBN 978-7-03-062604-2

3.《精准医学时代肝胆胰微创介入治疗学》人民卫生出版社，副主编，2018年12月出版，ISBN 978-7-117-27060-1

4.《影像引导下的肿瘤治疗：一种多学科治疗方法》辽宁科学技术出版社，副主译，“2018年8月出版”，ISBN 978-7-5591-0929-3

5.《胰腺整合介入治疗学》同济大学出版社，参编，2019年12月出版，ISBN 978-7-5608-8451-6

6.《介入放射学》人民卫生出版社，参编，2018年3月出版，ISBN 978-7-117-26809-7

近三年所获的专利：

1．一种核磁共振纳米材料的制备方法 （专利号： ZL 2017 1 0806451.8） 国家发明专利权 中华人民共和国国家知识产权局 2019.2.22 1/9

2．一种用于腹内疝网膜剥离器 （专利号：ZL 2017 2 0902408.7 ） 国家实用新型专利权 中华人民共和国国家知识产权局 2019.1.18 1/6

3．一种用于大网膜疝剥离器 （专利号：ZL 2017 2 0903415.9） 国家实用新型专利权 中华人民共和国国家知识产权局 2019.1.18 2/6

4．一种用于网膜疝回复器 （专利号：ZL 2017 2 0902387.9） 国家实用新型专利权 中华人民共和国国家知识产权局 2019.1.25 1/6

5．用于肝内门体静脉覆膜支架及支架置入装置 （专利号：ZL 2019 2 1576612.X） 国家实用新型专利权 中华人民共和国国家知识产权局 2020.6.23 1/7

6．微波消融装置（专利号：ZL 2019 2 1719691.5） 国家实用新型专利权 中华人民共和国国家知识产权局 2020.7.31 1/6

近三年主要科研获奖

1.“原发性肝癌早期筛检及介入治疗优化的临床应用研究” 2019年浙江省科技进步二等奖 1/9

2.“胃肠道肿瘤介入诊治关键技术的建立与应用” 2018年技术发明一等奖 3/6

3.“消化道恶性肿瘤综合介入治疗关键技术的建立与应用” 2018年上海市科技进步二等奖 2/9

4.“干扰素联合肝动脉化疗栓塞对肝癌微环境影响的实验研究” 2018年浙江省医药卫生科技二等奖 2/11

5.“基于多学科的肾脏疾病综合诊治评估体系的构建与推广” 2017年浙江省科技进步三等奖 1/7

近三年所获市级以上荣誉

1.2020年，国家百千万人才工程

2.2020年，国家有突出贡献中青年专家

3.2019年，中国医师协会“中国介入新锐奖”

4.2018年，国之名医·青年新锐

5.2018年，浙江省151人才工程重点资助培养人员

6.2019年，浙江省万人计划科技创新领军人才

7.2019年，浙江省劳动模范

8.2020年，浙江省高校领军人才培养计划创新领军人才

9.2018年，浙江省卫生创新人才

联系方式：E-mail: jjstcty@sina.com